Patient Assistance Programs

GSK offers several patient assistance programs to help eligible individuals without prescription medicine coverage obtain free GSK medicines through the mail. There is no cost associated with getting help from any of our patient assistance programs—GSK does not charge an administrative fee or enrollment fees.

NOTE: Some medicines are only available at a retail pharmacy and are not distributed through mail order.

You can enroll in one of our patient assistance programs in 3 easy steps. If at any time you need help enrolling, experienced GSK representatives are available by phone to walk you through the process.

Learn more about the variety of programs that exist.

Is Your Prescription Medicine Included?

An alphabetical list of the GSK medicines included by our patient assistance programs is provided below. To find out whether the medicine you’re taking is included in any GSK patient assistance program, click on the first letter of your medicine’s name. If your medicine is listed, you may further filter by patient assistance program. Then click Update. If your medicine is not in the list it may be because the medicine is not a GSK medicine, or because the medicine is not included in our programs or, based on your income you do not qualify for the patient assistance program.

  • ADVAIR DISKUS® 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) http://us.gsk.com/products/assets/us_advair.pdf
  • ADVAIR DISKUS® 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) http://us.gsk.com/products/assets/us_advair.pdf
  • ADVAIR DISKUS® 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) http://us.gsk.com/products/assets/us_advair.pdf
  • ADVAIR® HFA 115/21 (fluticasone propionate 115 mcg and salmeterol 21 mcg)Inhalation Aerosol http://us.gsk.com/products/assets/us_advair_hfa.pdf
  • ADVAIR® HFA 230/21 (fluticasone propionate 230 mcg and salmeterol 21 mcg)Inhalation Aerosol http://us.gsk.com/products/assets/us_advair_hfa.pdf
  • ADVAIR® HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol http://us.gsk.com/products/assets/us_advair_hfa.pdf
  • ALTABAX® (retapamulin ointment), 1% http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022055s002lbl.pdf
  • ANORO™ ELLIPTA® (umeclidinium and vilanterol inhalation powder) https://www.gsksource.com/gskprm/htdocs/documents/ANORO-ELLIPTA-PI-MG.PDF
  • ARNUITY™ ELLIPTA® (fluticasone furoate inhalation powder) https://www.gsksource.com/gskprm/htdocs/documents/ARNUITY-ELLIPTA-PI-PIL.PDF
  • AVANDIA® (rosiglitazone maleate) Tablets http://us.gsk.com/products/assets/us_avandia.pdf
  • AVODART® (dutasteride) Soft Gelatin Capsules http://us.gsk.com/products/assets/us_avodart.pdf
  • BACTROBAN CREAM® (mupirocin calcium cream, 2%) http://us.gsk.com/products/assets/us_bactroban_cream.pdf
  • BACTROBAN® NASAL OINTMENT (mupirocin calcium ointment, 2%) http://us.gsk.com/products/assets/us_bactroban_nasal.pdf
  • BECONASE AQ® (beclomethasone dipropionate, monohydrate ) Nasal Spray, 0.042% http://us.gsk.com/products/assets/us_beconase_aq.pdf
  • BENLYSTA® (belimumab) Injection http://us.gsk.com/products/assets/us_benlysta.pdf
  • BREO® ELLIPTA® (fluticasone furoate and vilanterol inhalation powder) http://us.gsk.com/products/assets/us_breo_ellipta.pdf
  • Boostrix® – tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine http://us.gsk.com/products/assets/us_boostrix.pdf
  • COREG CR® (carvedilol phosphate extended release capsules) http://us.gsk.com/products/assets/us_coregcr.pdf
  • Cervarix – human papillomavirus vaccine (types 16, 18) - recombinant, adjuvanted http://us.gsk.com/products/assets/us_cervarix.pdf
  • DUAC® Topical Gel (clindamycin phosphate 1%, benzoyl peroxide 5%) https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Duac/pdf/DUAC-PI-PIL.PDF
  • EPIVIR-HBV® (lamivudine) Oral Solution http://us.gsk.com/products/assets/us_epivir_hbv.pdf
  • EPIVIR-HBV® (lamivudine) Tablets http://us.gsk.com/products/assets/us_epivir_hbv.pdf
  • Engerix-B® – hepatitis B vaccine (recombinant) http://us.gsk.com/products/assets/us_engerixb.pdf
  • FABIOR™ (tazarotene) Foam https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Fabior/pdf/FABIOR-PI-PIL.PDF
  • FLOVENT® DISKUS® 100 mcg (fluticasone propionate inhalation powder, 100 mcg) http://us.gsk.com/products/assets/us_flovent.pdf
  • FLOVENT® DISKUS® 250 mcg (fluticasone propionate inhalation powder, 250 mcg) http://us.gsk.com/products/assets/us_flovent.pdf
  • FLOVENT® DISKUS® 50 mcg (fluticasone propionate inhalation powder, 50 mcg) http://us.gsk.com/products/assets/us_flovent.pdf
  • FLOVENT® HFA 110 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) http://us.gsk.com/products/assets/us_flovent_hfa.pdf
  • FLOVENT® HFA 220 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) http://us.gsk.com/products/assets/us_flovent_hfa.pdf
  • FLOVENT® HFA 44 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) http://us.gsk.com/products/assets/us_flovent_hfa.pdf
  • Havrix® (hepatitis A vaccine) https://www.gsksource.com/gskprm/htdocs/documents/HAVRIX.PDF
  • IMITREX® (sumatriptan) Nasal Spray http://us.gsk.com/products/assets/us_imitrex_nasal_spray.pdf
  • INCRUSE® ELLIPTA® (umeclidinium inhalation powder) https://www.gsksource.com/gskprm/htdocs/documents/INCRUSE-ELLIPTA-PI-PIL.PDF
  • JALYN (dutasteride and tamsulosin hydrochloride) Capsules http://us.gsk.com/products/assets/us_jalyn.pdf
  • LAMICTAL® (lamotrigine) Starter Kits http://us.gsk.com/products/assets/us_lamictal.pdf
  • LAMICTAL® (lamotrigine) Tablets, Chewable Dispersible Tablets or Orally Disintegrating Tablets http://us.gsk.com/products/assets/us_lamictal.pdf
  • LAMICTAL® ODT™ (lamotrigine) Patient Titration Kits http://us.gsk.com/products/assets/us_lamictal.pdf
  • LAMICTAL® XR™ http://us.gsk.com/products/assets/us_lamictalxr.pdf
  • LAMICTAL® XR™ (lamotrigine) Patient Titration Kits http://us.gsk.com/products/assets/us_lamictalxr.pdf
  • LOVAZA® (omega-3-acid ethyl esters) Capsules http://us.gsk.com/products/assets/us_lovaza.pdf
  • MALARONE® (atovaquone and proguanil hydrochloride) Tablets http://us.gsk.com/products/assets/us_malarone.pdf
  • MEPRON® (atovaquone) Suspension http://us.gsk.com/products/assets/us_mepron.pdf
  • POTIGA® (ezogabine) Tablets http://us.gsk.com/products/assets/us_potiga.pdf
  • RELENZA® (zanamivir) inhalation powder for oral inhalation http://us.gsk.com/products/assets/us_relenza.pdf
  • REQUIP® XL™ (ropinirole extended-release tablets) http://us.gsk.com/products/assets/us_requipxl.pdf
  • RYTHMOL® SR (propafenone hydrochloride) extended release Capsules http://us.gsk.com/products/assets/us_rythmolsr.pdf
  • SEREVENT® DISKUS® (salmeterol xinafoate inhalation powder) http://us.gsk.com/products/assets/us_serevent_diskus.pdf
  • SORIATANE® (acitretin) Capsules https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Soriatane/pdf/SORIATANE-PI-MG.PDF
  • SORILUX® (calcipotriene) Foam https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Sorilux/pdf/SORILUX-FOAM-PI-PIL.PDF
  • TANZEUM® (albiglutide) for injection, for subcutaneous use https://www.gsksource.com//gskprm/htdocs/documents/TANZEUM-PI-MG-IFU-COMBINED.PDF
  • Twinrix® – combined hepatitis A (inactivated virus) and hepatitis B vaccine http://us.gsk.com/products/assets/us_twinrix.pdf
  • VELTIN® Gel (clindamycin phosphate/tretinoin) 1.2%/0.025% https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Veltin_Gel/pdf/VELTIN-GEL-PI-PIL.PDF
  • VENTOLIN® HFA (albuterol sulfate HFA inhalation aerosol) http://us.gsk.com/products/assets/us_ventolin_hfa.pdf
  • VERAMYST® (fluticasone furoate) Nasal Spray http://us.gsk.com/products/assets/us_veramyst.pdf
  • Update

    GSK Access

    GSK Access provides certain GSK prescription medicines — at no cost — to qualified patients who are enrolled in a Medicare Part D Prescription Medicine Plan. This program does not constitute health insurance.

    Learn More

    BRIDGES TO ACCESS®

    Bridges to Access provides certain GSK prescription medicines — at no cost — to qualified patients. You may enroll in the program on your own by mail, or through an Advocate if medicine is needed that same day. This program does not constitute health insurance.

    Learn More

    Immunology Assistance Programs

    These include a co-pay assistance program and patient assistance program. For more information, please call 1-877-423-6597. This program does not constitute health insurance.

    Learn More

    GSK Vaccines Access Program

    GSK Vaccines Access Program provides certain GSK vaccines to adult applicants who meet eligibility requirements.

    Learn More

    Reimbursement Resources Center

    This toll-free reimbursement support program helps patients and healthcare professionals in the U.S. with coverage, coding, and reimbursement issues for certain GSK products.

    Learn More

    You are about to leave a GlaxoSmithKline website. By clicking this link, you will be taken to a website that is independent from GlaxoSmithKline. The site you are linking to is not controlled or endorsed by GlaxoSmithKline and GlaxoSmithKline is not responsible for the content provided on that site.